Test Price
2,800 AED✅ Home Collection Available
HOXB1 Gene Facial Paresis Type 3 Genetic Test in UAE
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO 9001:2015 accredited Next‑Generation Sequencing (NGS) at our CAP‑certified laboratory.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection (available daily from 8 AM to 11 PM).
- Clinical Guidance: Complimentary telephonic post‑test clinical result interpretation with a DHA‑licensed genetic counsellor.
- Insurance Support: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The HOXB1 Gene Facial Paresis Type 3 NGS Test is a comprehensive next‑generation sequencing analysis that detects pathogenic variants in the HOXB1 gene, confirming hereditary congenital facial palsy type 3. This investigation provides definitive molecular confirmation for affected individuals and informs reproductive risk assessment through genetic counselling. The method covers the full coding region plus ±10 bp flanking intronic sequence, enabling detection of single‑nucleotide variants, small insertions/deletions, and copy number variations.
| Feature | Our Test (NGS Full Gene) | Closest Alternative |
|---|---|---|
| Diagnostic Precision | 99.9% sensitivity – full coding region ±10 bp flanking intronic sequence | Single‑exon Sanger sequencing; may miss deep intronic variants |
| Methodology | Next‑Generation Sequencing (Illumina NovaSeq) with bioinformatic‑driven CNV calling | Sanger sequencing or generic multi‑gene panel without dedicated HOXB1 coverage |
| Turnaround Time | 3–4 weeks | 4–6 weeks |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh | Consultant Medical Genetics | DHA Registration ID: 9294403: “A genetic diagnosis of HOXB1‑related facial paresis can bring both clarity and emotional weight. This test offers a definitive answer, but each result must be interpreted together with your family history and clinical presentation. My team and I provide compassionate pre‑ and post‑test counselling to help you understand the implications and plan next steps.”
Safety Considerations & Exclusion Criteria
- This test is for diagnostic purposes only; it is not a pre‑symptomatic screening tool for healthy individuals.
- Mandatory pre‑test genetic counselling session to construct a three‑generation pedigree chart.
- Do not proceed if the patient is unable to give valid informed consent; refer to Federal Decree‑Law No. 4 of 2016 on Medical Liability for consent requirements regarding minors.
- Emergency red flags: sudden worsening of facial weakness, inability to close the eye, difficulty breathing, or signs of stroke – seek immediate emergency care.
Patient FAQ & Clinical Guidance
1. What is the HOXB1 gene facial paresis type 3 test, and who should consider it?
Quick Answer: A Next‑Generation Sequencing test that examines the entire HOXB1 gene for mutations causing hereditary congenital facial palsy type 3. It is recommended for individuals with a clinical suspicion of congenital facial palsy, especially those with a family history of the condition.
2. How is the test performed in the UAE, and what is the cost?
Quick Answer: A simple blood sample is collected via VIP Home Phlebotomy (daily 8 AM–11 PM) or at our Dubai Healthcare City facility. The test costs 2,800 AED with results in 3–4 weeks.
3. Is post‑genetic counselling available, and does insurance cover it?
Quick Answer: Yes, complimentary telephonic genetic counselling by a DHA‑licensed consultant geneticist is included. Direct billing to most major insurance providers is available after verification.
UAE Regulatory & Data Privacy Adherence
100% DHA & MOHAP Compliant
This service strictly adheres to the UAE’s Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is processed exclusively within the UAE. Our laboratory holds ISO 9001:2015 certification (INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | HOXB1 Gene Facial Paresis Type 3 Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Peripheral Whole Blood (3–5 mL in EDTA tube) |
| Methodology Used | Next‑Generation Sequencing (Illumina NovaSeq) with CNV calling |
| ICD-10-CM Code | Q87.0 |
| LOINC Code | 89724-1 |
| DHA Facility License & Address | DHA License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians